2028 年胃癌诊断程序市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00029842
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 398
Buy Now

Gastric Cancer Diagnostic Procedure Market Growth & Analysis 2028

Buy Now

 

胃癌诊断程序市场预计将从 2022 年的 13.0796 亿美元增长到 2028 年的 19.1203 亿美元;预计 2022 年至 2028 年的复合年增长率为 6.5%。

胃癌诊断程序市场根据医疗保健提供者、症状类型、体液、程序、产品、疾病指征和地理位置进行细分。该报告提供了对市场的见解和深入分析,强调了胃癌诊断程序市场的动态、趋势和机会等参数,以及各地区主要市场参与者的竞争格局分析。它还包括 COVID-19 大流行对这些地区市场的影响分析。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

胃癌诊断程序市场:

Gastric Cancer Diagnostic Procedure Market: Strategic Insights

Gastric Cancer Diagnostic Procedure Market
  • CAGR
    CAGR (2022 - 2028)
    6.5%
  • Market Size 2022
    US$ 1.31 Billion
  • Market Size 2028
    US$ 1.91 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Atlas Link Biotech Co Ltd
  • Bio Rad Laboratories Inc
  • MiRXES Pte Ltd
  • Agilent Technologies Inc
  • F Hoffmann La Roche Ltd
  • bioMerieux SA
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Vela Diagnostics Holding Pte Ltd

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1医疗保健提供者(诊断实验室、医院、癌症研究机构、肿瘤专科诊所等)
    Segment2症状类型(有症状和无症状)
      Segment3体液(血液、尿液、唾液、胃洗液/胃液、组织等)
        Segment4程序(内窥镜检查、活检和组织测试、实验室测试、体外诊断测试、影像学测试、分子诊断、多路复用分子诊断和免疫测定等)

          胃癌诊断程序市场
          • Gastric Cancer Diagnostic Procedure Market
            复合年增长率(2022 - 2028)
            6.5%
          • 2022 年市场规模
            13.1 亿美元
          • 2028 年市场规模
            19.1 亿美元

          市场动态

          增长动力
          • 財政部
          • 財政部
          • 財政部
          未来的趋势
          • 財政部
          • 財政部
          • 財政部
          机会
          • 財政部
          • 財政部
          • 財政部

          关键人物;主力;重要一员

          •  
          • 亚特拉斯联生物科技股份有限公司
          • Bio-Rad 实验室公司
          • MiRXES 私人有限公司
          • 安捷伦科技公司
          • F. 霍夫曼-罗氏有限公司
          • 生物梅里埃公司
          • 赛默飞世尔科技公司
          • Illumina公司
          • Vela Diagnostics 控股私人有限公司

          区域概况

          Gastric Cancer Diagnostic Procedure Market
          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          Gastric Cancer Diagnostic Procedure Market医疗服务提供方
          • 诊断实验室
          • 医院
          • 癌症研究机构
          • 肿瘤专科诊所
          • 其他的
          Gastric Cancer Diagnostic Procedure Market症状类型
          • 有症状和无症状
          Gastric Cancer Diagnostic Procedure Market体液
          • 尿
          • 唾液
          • 洗胃液/胃液
          • 组织
          • 其他的
          Gastric Cancer Diagnostic Procedure Market程序
          • 内窥镜检查
          • 活检和组织检查
          • 实验室测试
          • 体外诊断测试
          • 影像学检查
          • 分子诊断
          • 多重分子诊断和免疫测定
          • 其他的
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          市场洞察

           

           

          胃肠道疾病患病率上升

           

          尽管近几十年来胃癌的发病率和死亡率有所下降,但胃癌仍被视为全球主要的健康挑战之一。根据 GLOBOCAN 的数据,2020 年胃癌导致约 800,000 人死亡(占所有癌症相关死亡的 7.7%)。该疾病是男女癌症死亡的第四大原因。2020 年诊断出约 110 万例新胃癌病例,占所有癌症病例的 5.6%。亚洲占全球报告的新胃癌病例和死亡人数的约 75%。美国和加拿大等西方国家报告的胃肠道疾病发病率很高,这可以归因于成年人口肥胖增加和膳食纤维摄入减少。根据美国疾病控制和预防中心 2022 年 12 月发布的数据,美国医生办公室记录了约 3720 万例消化系统疾病。

          近几十年来,肠易激综合征 (IBS) 的发病率在世界范围内不断上升。根据国际胃肠病基金会的数据,IBS 是最常见的功能性胃肠道疾病,全球发病率为 10-15%。此外,美国医生每年记录的 IBS 患者就诊量约为 240-350 万。尽管近年来胃癌的总体发病率一直在下降,但过去几十年来,年轻人的胃癌发病率却大幅上升。因此,胃肠道 (GI) 疾病的发病率不断上升导致罹患胃癌的风险很高,从而推动了胃癌诊断程序市场的增长。

           

          基于医疗保健提供商的见解

          根据医疗保健提供商,全球胃癌诊断程序市场分为诊断实验室、医院、癌症研究机构、肿瘤专科诊所等。2022 年,医院部门占据了最大的市场份额。预计在预测期内,癌症研究机构部门的市场将以最高的复合年增长率增长。

           

          基于症状类型的见解

           

          根据症状类型,胃癌诊断程序市场分为有症状和无症状两类。2022 年,无症状部分占据了更大的市场份额。然而,预计有症状部分在预测期内的复合年增长率会更高。

           

          基于体液的见解

          根据体液,胃癌诊断程序市场细分为血液、尿液、唾液、胃冲洗液/胃液、组织和其他。2022 年,血液部分占据了最大的市场份额。然而,预计组织部分的市场在预测期内将以最快的复合年增长率增长。

           

          基于流程的洞察

          根据程序,胃癌诊断程序市场细分为内窥镜检查、活检和组织测试、实验室测试、体外诊断测试、影像测试、分子诊断、多路复用分子诊断和免疫测定等。2022 年,影像测试部分占据最大的市场份额。预计活检和组织测试部分的市场在预测期内将实现更高的复合年增长率。

           

          基于产品的洞察

          根据产品类型,胃癌诊断程序市场分为仪器、试剂和耗材以及服务。2022 年,试剂和耗材部分占据了最大的市场份额。预计服务部分市场在预测期内的复合年增长率会更高。

           

          基于疾病指征的见解

          根据疾病指征,胃癌诊断程序市场分为早期胃癌和晚期胃癌。2022 年,晚期胃癌细分市场占据了更大的市场份额。预计同一细分市场的市场在预测期内将以更高的复合年增长率增长。

           

          COVID-19 洞察

          为减少 SARS-CoV-2 的传播,一些国家实施了预防措施,例如刻意扩大物理空间以避免密切接触和疾病传播,以及强制在工作场所使用口罩。然而,各种限制导致胃癌诊断和治疗的预约被取消或重新安排。根据 2021 年在 PubMed 上发表的一项研究,在 COVID-19 期间,被诊断出患有 I 期胃癌和结直肠癌的患者数量明显减少。2020 年第一季度后,政府和私人机构对 COVID-19 患者进行幽门螺杆菌感染检测的胃癌诊断需求增加。此外,晚期胃癌患者被优先诊断和治疗,这导致 COVID-19 危机期间胃癌诊断程序市场增长。

           

          胃癌诊断程序市场报告范围

          报告属性细节
          2022 年市场规模13.1亿美元
          2028 年市场规模19.1亿美元
          全球复合年增长率(2022 - 2028)6.5%
          历史数据2020-2021
          预测期2023-2028
          涵盖的领域按医疗保健提供者
          • 诊断实验室
          • 医院
          • 癌症研究机构
          • 肿瘤专科诊所
          • 其他的
          按症状类型
          • 有症状和无症状
          通过体液
          • 尿
          • 唾液
          • 洗胃液/胃液
          • 组织
          • 其他的
          按程序
          • 内窥镜检查
          • 活检和组织检查
          • 实验室测试
          • 体外诊断测试
          • 影像学检查
          • 分子诊断
          • 多重分子诊断和免疫测定
          • 其他的
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          •  
          • 亚特拉斯联生物科技股份有限公司
          • Bio-Rad 实验室公司
          • MiRXES 私人有限公司
          • 安捷伦科技公司
          • F. 霍夫曼-罗氏有限公司
          • 生物梅里埃公司
          • 赛默飞世尔科技公司
          • Illumina公司
          • Vela Diagnostics 控股私人有限公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

           

          胃癌诊断程序市场参与者采用产品发布和扩张等有机策略来扩大其全球足迹和产品组合并满足不断增长的需求。合作伙伴关系和协作是市场上见证的无机增长战略之一。这些增长战略使市场参与者能够扩大业务并增强其地理影响力。此外,收购、合作伙伴关系和其他增长战略有助于公司加强客户群并增加其产品组合。

          • 2023 年 2 月,CARsgen Therapeutics 宣布与 F. Hoffmann-La Roche(罗氏)达成合作协议,以评估 AB011 和阿替利珠单抗治疗胃癌的效果。此次合作将评估 CARsgen 的试验药物 AB011、罗氏的 PD-L1 检查点抑制剂阿替利珠单抗以及标准化疗组合在胃癌或胃食管交界处癌患者中的疗效。
          • 2023 年 1 月,安捷伦科技宣布与 Akoya Biosciences 合作,为致力于开发精准癌症疗法的生物制药公司开发包括空间分析在内的显色和免疫荧光多重检测。此次合作建立了一个生态系统,有助于开发新型精准癌症疗法,并为这两家公司在临床研究市场的客户提供简化的工作流程。
          • 2022 年 8 月,MiRXES 推出了一系列新功能,包括工业 4.0 制造工厂、两个新实验室和一个合作的多癌症筛查研究项目。这些新发展符合 MiRXES 的目标,即提高其研究和生产能力,开发基于 miRNA 的疾病检测测试。
          • 2022年7月,MiRXES Pte Ltd启动了全球首个大型临床研究项目——CADENCE(CAncer Detected Early caN be CurEd)。CADENCE项目旨在开发一种针对多达九种高发病率和高死亡率癌症的多癌种早期检测测试:肺癌、乳腺癌、结直肠癌、肝癌、胃癌、食道癌、卵巢癌、胰腺癌和前列腺癌。

           

          胃癌诊断程序市场 - 公司简介

          • 亚特拉斯联生物科技股份有限公司
          • Bio-Rad 实验室公司
          • MiRXES 私人有限公司
          • 安捷伦科技公司
          • F. 霍夫曼-罗氏有限公司
          • 生物梅里埃公司
          • 赛默飞世尔科技公司
          • Illumina公司
          • Vela Diagnostics 控股私人有限公司
          • Myraid 基因公司

          Gastric Cancer Diagnostic Procedure Market Report Scope

          Report Attribute Details
          Market size in US$ 1.31 Billion
          Market Size by US$ 1.91 Billion
          Global CAGR 6.5%
          Historical Data 2020-2021
          Forecast period 2023-2028
          Segments Covered By 医疗保健提供者(诊断实验室、医院、癌症研究机构、肿瘤专科诊所等)
          By 症状类型(有症状和无症状)
          By 体液(血液、尿液、唾液、胃洗液/胃液、组织等)
          By 程序(内窥镜检查、活检和组织测试、实验室测试、体外诊断测试、影像学测试、分子诊断、多路复用分子诊断和免疫测定等)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • Atlas Link Biotech Co Ltd
        • Bio Rad Laboratories Inc
        • MiRXES Pte Ltd
        • Agilent Technologies Inc
        • F Hoffmann La Roche Ltd
        • bioMerieux SA
        • Thermo Fisher Scientific Inc
        • Illumina Inc
        • Vela Diagnostics Holding Pte Ltd
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          What are the driving factors for the global gastric cancer diagnostic procedure market across the world?

          The factors that are driving the growth of the gastric cancer diagnostic procedure market are the rise in alcohol consumption, smoking, surging cases of Helicobacter pylori infection, and the rise in the prevalence of gastrointestinal diseases. These are some of the major factors contributing to the growth of the gastric cancer diagnostic procedure industry.

          What is the gastric cancer diagnostic procedure?

          Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.

          Who are the major players in the gastric cancer diagnostic procedure market across the globe?

          The gastric cancer diagnostic procedure market majorly consists of the players, such as Atlas-Link Biotech Co Ltd, Bio-Rad Laboratories Inc, MiRXES Pte Ltd, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc, Illumina Inc, Vela Diagnostics Holding Pte Ltd, and Myraid Genetics Inc.

          What is the estimated gastric cancer diagnostic procedure market size in 2022?

          The gastric cancer diagnostic procedure market is estimated to be valued at US$ 1307.96 million in 2022.

          What is the market CAGR value of the gastric cancer diagnostic procedure market during the forecast period?

          The CAGR value of the gastric cancer diagnostic procedure market during the forecasted period is 6.5%%.

          Which region is projected to be the fastest-growing region in the global gastric cancer diagnostic procedure market?

          The Asia Pacific is expected to be the fastest-growing region in the gastric cancer diagnostic procedure market over the forecast period due to the increasing surging cases of helicobacter pylori infection and the rise in the prevalence of gastrointestinal diseases.

          What are the growth estimates for the gastric cancer diagnostic procedure market till 2028?

          The gastric cancer diagnostic procedure market is expected to be valued at US$ 1912.03 million by 2028.

          Which segment by healthcare provider led the gastric cancer diagnostic procedure market?

          The hospitals segment held the largest share of the market in 2022. Also, the cancer research institutes segment is estimated to register the highest CAGR in the market during the forecast period.

          The List of Companies - Gastric Cancer Diagnostic Procedure Market

          1. Atlas-Link Biotech Co Ltd
          2. Bio-Rad Laboratories Inc
          3. MiRXES Pte Ltd
          4. Agilent Technologies Inc
          5. F. Hoffmann-La Roche Ltd
          6. bioMerieux SA
          7. Thermo Fisher Scientific Inc
          8. Illumina Inc
          9. Vela Diagnostics Holding Pte Ltd
          10. Myraid Genetics Inc.

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Trends and growth analysis reports related to Medical Device : READ MORE..